Please sign in to follow a disease.
Inflammatory breast carcinoma
MONDO:0006804An advanced, invasive breast adenocarcinoma characterized by the presence of distinct changes in the overlying skin. These changes include diffuse erythema, edema, peau d'orange (skin of an orange) appearance, tenderness, induration, warmth, enlargement, and in some cases a palpable mass. The skin changes are the consequence of lymphatic obstruction from the underlying invasive breast adenocarcinoma. Microscopically, the dermal lymphatics show prominent infiltration by malignant cells. The invasive breast adenocarcinoma is usually of ductal, NOS type. There is not significant inflammatory cell infiltrate present, despite the name of this carcinoma.
Also known as: inflammatory breast cancer, inflammatory breast carcinoma, inflammatory carcinoma of breast, inflammatory carcinoma of the breast, mastitis Carcinomatosa, mastitis carcinomatosa, IBC, breast cancer, inflammatory
2827 clinical trials for this condition and its sub-types, 29 tagged with Inflammatory breast carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Experimental cocktail aims to outsmart Hard-to-Treat breast cancer
Disease control Recruiting nowThis early-phase trial is testing a new combination of three drugs—cyclophosphamide, axatilimab, and retifanlimab—in people with metastatic triple negative breast cancer that has stopped responding to standard treatments. The main goal is to find the safest dose of the new combin…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New drug cocktail aims to wipe out rare, aggressive breast cancer before surgery
Disease control Recruiting nowThis phase II trial is testing whether combining two drugs—trastuzumab deruxtecan (Enhertu) and durvalumab—given before surgery can eliminate cancer in people with stage III inflammatory breast cancer that has HER2 protein. The study will enroll 63 participants and measure how ma…
Phase 2 • Sponsor: Filipa Lynce, MD • Aim: Disease control
Last updated Jun 26, 2026 19:08 UTC
-
New surgery aims to stop lymphedema before it starts
Prevention Recruiting nowThis study tests whether a procedure called lymphovenous bypass, done before underarm lymph node removal, can prevent lymphedema (arm swelling) in patients with breast cancer or melanoma. About 252 participants will receive the bypass during their cancer surgery. Researchers will…
Sponsor: M.D. Anderson Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 12:37 UTC
-
Virtual workouts may protect heart health in breast cancer patients on chemo
Symptom relief Recruiting nowThis study tests whether a virtual exercise and education program can help breast cancer patients maintain their fitness, heart health, and quality of life while undergoing chemotherapy. About 120 patients with stage I-III breast cancer will be enrolled. Participants will attend …
Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New registry aims to decode MRD testing in rare, aggressive breast cancer
Knowledge-focused Recruiting nowThis study is a registry that collects information from 200 people with stage III or IV inflammatory breast cancer (IBC). Participants fill out a quality-of-life questionnaire and provide blood samples for MRD testing. The goal is to gather data on how MRD test results relate to …
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
New registry aims to unlock secrets of rare breast cancer
Knowledge-focused Recruiting nowThis study creates a registry for people with inflammatory breast cancer, a rare and aggressive form of the disease. Researchers will collect blood, tissue, and stool samples along with medical information from up to 1,200 participants. The goal is to build a resource for future …
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Blood clues: can tumor cell clusters predict breast cancer treatment success?
Knowledge-focused Recruiting nowThis study is for people with high-risk early breast cancer, including inflammatory breast cancer. Researchers want to see if clusters of tumor cells found in the blood can help predict how well treatment works and the chances of survival. About 130 participants will give blood s…
Sponsor: Institute of Oncology Ljubljana • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Could a simpler biopsy replace major surgery for inflammatory breast cancer?
Knowledge-focused Recruiting nowThis study looks at whether a less invasive procedure called sentinel lymph node biopsy can be safely used after chemotherapy in people with inflammatory breast cancer. Traditionally, these patients need more extensive surgery because the cancer is advanced. The study will check …
Sponsor: European Institute of Oncology • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
New study aims to improve lymph node detection in rare breast cancer
Knowledge-focused Recruiting nowThis study looks at whether special imaging and dye can help doctors find the first lymph nodes that cancer might spread to in people with inflammatory breast cancer. About 50 women with this rare and aggressive cancer will take part. The goal is to see if these methods work well…
Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC